Work

Abstract 926: Extrinsic and intrinsic activation of RAS/MAPK signaling enables resistance to FLT3 inhibitor, gilteritinib, in acute myeloid leukemia

Year: 2019

Type: conference-abstract

Source: Experimental and Molecular Therapeutics

DOI: 10.1158/1538-7445.sabcs18-926

Authors: Sunil K. Joshi, Stephen Christy, Renata Scopim Ribeiro, Shannon McWeeney, Jeffrey W. Tyner, Cristina E. Tognon, Brian J. Druker, Elie Traer

Institutions: Howard Hughes Medical Institute, Oregon Health & Science University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4255571618

Cites:

Cited by:

Related to: 10